Intervention

Atezolizumab 1200 mg in 20 ML Injection

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting2

Common conditions3

Lead sponsors shown3

Clinical trials

3 shown

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)NCT05332561 · 2023-06-29

Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)NCT04996017 · 2021-12-14

Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung CancerNCT04487756 · 2021-03-17

Common conditions

Early-stage Breast Cancer1 Extensive-stage Small Cell Lung Cancer1 Mesotheliomas Pleural1

Leading sponsors

German Cancer Research Center1 Gruppo Oncologico Italiano di Ricerca Clinica1 Instituto Oncológico Dr Rosell1

Trial status mix

RECRUITING2

COMPLETED1

Phase mix

PHASE22

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.